Walgreens Boots Alliance — Debt Investor Presentation (May 2016)
31 slides from Walgreens Boots Alliance's debt investor presentation, May 9, 2016
Slide 1: Fixed income investor presentation May 2016
Fixed income investor presentation May 2016 Exhibit 99.1
Slide 2: Forward-looking statements and offering disclaimer
Statements in these materials that are not historical are forward-looking statements made based on current market, business and regulatory expectations and involve risks, uncertainties and assumptions that could cause actual results to vary materially. Except to the extent required by the law, we un
Slide 3: Agenda
Agenda Company highlights 4 WBA segments and brands overview11 Pending Rite Aid acquisition overview19 Q&A23 Appendix24
Slide 4: Company highlights
Company highlights 5 " Walgreens Boots Alliance
Slide 5: A market leader with complementary capabilities and assets
Company highlights 10 A market leader with complementary capabilities and assets Significant global size and scale Diversified revenue and profit pools Synergy track record Commitment to solid investment grade rating Strong management team with track record of success
Slide 6: Walgreens Boots Alliance today
LTM sales to external customers by division Financial highlights A leader in the retail pharmacy industry A leading global pharmaceutical wholesaler and distributor A leading drugstore chain in the USA The first global pharmacy-led, health and wellbeing enterprise in the world Walgreens Boots Allian
Slide 7: Unique global presence
Unique global presence One of the largest global pharmaceutical wholesale and distribution networks with over 3501 distribution centers in 191 countries One of the largest retail pharmacy, health and daily living destinations in the USA and Europe One of the world’s largest purchasers of prescriptio
Slide 8: Large scale and cash flow generation
Large scale and cash flow generation Net sales Adjusted operating income2 Leverage as of February 29, 2016 Free cash flow generation2 1 LTM as of February 29, 2016 2 Non GAAP financial measure – see attached Appendix 3 Adjusted by adding rent expense using a multiple of 8. Rent expense based on FY 2
Slide 9: Synergy track record: Walgreens-Alliance Boots transaction
Synergy track record: Walgreens-Alliance Boots transaction ($ millions) 1 For FY 2013 only full year realized synergies reported 1
Slide 10: Financial policy and strategy
Financial policy and strategy1 Committed to solid investment grade credit ratings Optimal for an enterprise of our size and scale Important for maintaining significant access to commercial paper Supported by current share repurchase suspension (other than anti-dilutive activity associated with emplo
Slide 11: WBA segments and brands overview
WBA segments and brands overview
Slide 12: Retail Pharmacy USA segment
Retail Pharmacy USA segment Two great retail pharmacy brands: Walgreens and Duane Reade 8,1871 drugstores in 501 states, the District of Columbia, Puerto Rico and the US Virgin Islands Approximately 68 million visits per month to Walgreens websites as of August 31, 2015 Approximately 76% of the popu
Slide 13: Building an even better Walgreens
Building an even better Walgreens1 Enabled by sophisticated, focused IT systems that support these core activities 1 Forward-looking statements – see cautionary note in attached Appendix Recapture our position as America’s most loved pharmacy Focus on dispensing Front of store margin expansion Devel
Slide 14: Pharmacy experience and operations
Pharmacy experience and operations Growth in prescription volume1 19.5%2 prescription market share Relationships with payers Patient experience Patient access Medicare Part D growth strategy OptumRx Select 90 Express Scripts Smart 90 Specialty pharmacy Specialty at retail Leveraging our national cen
Slide 15: Front of store margin expansion
Front of store margin expansion Optimizing assortment and space Expanding health and beauty space Format trials Rolling out new beauty experience in 2016 No7, Soap & Glory and Botanics Service model and enhanced enviornment Focused on delivering reliable value Enhanced promotional strategy Omnichann
Slide 16: Retail Pharmacy International segment
Retail Pharmacy International segment Strong market positions in Europe, Latin America and Asia Principal retail brands: Boots in the United Kingdom, Thailand, Norway, the Republic of Ireland, The Netherlands and Lithuania, Farmacias Ahumada in Chile and Farmacias Benavides in Mexico 4,6031 pharmacy
Slide 17: Pharmaceutical Wholesale segment
Pharmaceutical Wholesale segment A leading pharmaceutical wholesaler in Europe Mainly operating under the Alliance Healthcare brand A network of 3021 distribution centers delivering medicines, other healthcare products and related services to more than 140,0002 pharmacies, doctors, health centers an
Slide 18: Owned product brands
Owned product brands Portfolio of highly regarded and long established product brands, which we continue to internationalize
Slide 19: Pending Rite Aid acquisition overview
Pending Rite Aid acquisition overview
Slide 20: Rite Aid business overview
Rite Aid business overview1 Revenues Retail Pharmacy revenue by product2 Adjusted EBITDA3 ($ millions) ($ millions) Geographical split2 104 139 37 190 22 81 91 72 224 604 1 225 26 275 79 62 116 10 13 179 20 580 93 537 68 146 44 77 257 42 140 MD 7 D.C. Rite Aid States / Store Count Rite Aid Distribut
Slide 21: Acquisition overview
Acquisition overview Offer price $9.00 per share in cash, total enterprise value of $16.6 billion1 Rite Aid shareholder approval Rite Aid shareholders approved on 4 February 2016 Regulatory approval Subject to regulatory approval and other customary closing conditions Contract provides for divestmen
Slide 22: Strategic rationale
Strategic rationale Acquisition rationale Complements Walgreens footprint, filling gaps in the Northeast and Southern California Economies of scale create efficiencies and cost savings Provides opportunity to develop the Rite Aid retail product offering Shift to improve category mix Expand distribut
Slide 23: Q&A
Q&A
Slide 24: Appendix
Appendix = Walgreens Boots Alliance
Slide 25: Reconciliation of supplemental non-GAAP financial measures
The following information provides reconciliations of the supplemental non-GAAP financial measures, as defined under SEC rules, presented in this presentation to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles in th
Slide 26: Reconciliation of non-GAAP financial measures: free cash flow
Reconciliation of non-GAAP financial measures Note: LTM as of February 29, 2016 1 Free cash flow is defined as net cash provided by operating activities in a period minus additions to property, plant and equipment (capital expenditures) made in that period. This measure does not represent residual c
Slide 27: Adjusted Operating Income, EBITDA and Adjusted Debt
Walgreens Boots Alliance, Inc. and Subsidiaries FY 2014 FY 2015 2H FY 2015 1H FY 2016 2016 LTM Adjusted Operating Income, EBITDA and Adjusted Debt 12M ending Aug 31 12M ending Aug 31 6M ending Aug 31 6M ending Feb 29 12M ending Feb 29 (In millions) Operating Income (GAAP) $ 4,194 $ 4,668 $ 2,237 $ 3
Slide 28: Adjusted Net Earnings reconciliation
Note: LTM as of February 29, 2016 1 Net investment hedge gains/losses are reported as an adjustment prospectively beginning in FY15 4Q. Net investment hedge gains of $10 million or $0.01 per share in FY15 2Q and $7 million or $0.01 per share in FY15 3Q were included in the company’s GAAP and adjuste
Slide 29: Adjusted Net Earnings per Share reconciliation
Note: LTM as of February 29, 2016 1 Net investment hedge gains/losses are reported as an adjustment prospectively beginning in FY15 4Q. Net investment hedge gains of $10 million or $0.01 per share in FY15 2Q and $7 million or $0.01 per share in FY15 3Q were included in the company’s GAAP and adjuste
Slide 30: Rite Aid reconciliation of non-GAAP financial measures
Rite Aid - Reconciliation of non-GAAP financial measures Note: Data presented for Rite Aid 52 week periods ending March 1, 2014, February 28, 2015 and February 27,2016. Based on reconciliation provided in Rite Aid Annual Report on Form 10-K for the 52 week period ending February 27, 2016, filed with
Slide 31: Cautionary note regarding forward-looking statements
This Presentation includes “forward‐looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on current expectations, estimates, forecasts and projections about Walgreens Boots A
Walgreens Boots Alliance — Debt Investor Presentation (May 2016) on 6ix